GENE ONLINE|News &
Opinion
Blog

Regulatory
The U.S. FDA Grants Orphan Drug Designation to NS-089/NCNP-02 for the Treatment of DMD
2023-08-17
Bavarian Nordic Closes on Valneva in Chikungunya Vaccine Race
2023-08-14
Vistagen’s Positive Phase 3 Results for Social Anxiety Treatment
2023-08-10
FDA Approves GSK’s PD-1 Medicine for Early-Detected Endometrial Cancer
2023-08-06
2023 Precision Medicine Industry Policy White Paper Paves the Way for the Biotechnology in Taiwan
2023-07-24
Sanofi and AstraZeneca’s RSV Antibody Drug Gets FDA Approval, Adding New Weapon for Preventing Infant Infections
2023-07-18
The First Non-prescription Oral Contraceptive approved by FDA
2023-07-18
FDA Granted Eisai and Biogen’s New Alzheimer’s Drug a Traditional Approval, Making Medicare Coverage Possible
2023-07-11
FDA Approves Pfizer’s Human Growth Hormone Drug
2023-07-03
The Gates Foundation and Wellcome Join Forces to Fund Late-Stage Tuberculosis Vaccine
2023-06-29
Lilly’s Oral GLP-1 Agonist Shows Encouraging Results for Weight Management
2023-06-28
Clinical Hold Announced for Arcellx’s IMMagine-1 Phase 2 Clinical Program
2023-06-27
Promising Clinical Data Supports Clinical Initiation of Epic Bio’s FSHD Therapy
2023-06-27
Valneva’s Breakthrough Chikungunya Single-shot Vaccine: Release Phase 3 Data
2023-06-16
Recent Highlights of the RSV Vaccine Battle, with More Regulatory Approvals in Sight
2023-06-08
1 2 3 4 5 53
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top